Shobokshi, Amal <br/><br/>
Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy.  [electronic resource] 

 -  Journal of the Society for Gynecologic Investigation  Feb 2003 
 - 99-104 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1071-5576 
<br/><br/><label>Standard No.: </label>10.1016/s1071-5576(02)00260-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>Clomiphene--therapeutic use<br/>Drug Therapy, Combination<br/>Estrogen Antagonists--therapeutic use<br/>Female<br/>Follicle Stimulating Hormone--blood<br/>Humans<br/>Hyperandrogenism--complications<br/>Hypoglycemic Agents--therapeutic use<br/>Insulin Resistance<br/>Insulin-Like Growth Factor Binding Protein 3--blood<br/>Insulin-Like Growth Factor I--drug effects<br/>Luteinizing Hormone--blood<br/>Menstruation<br/>Polycystic Ovary Syndrome--complications<br/>Rosiglitazone<br/>Thiazoles--therapeutic use<br/>Thiazolidinediones